The thermal stability of triprolidine hydrochloride and its mixtures with cyclodextrin and glucose

Journal of Thermal Analysis and Calorimetry

Volumn 77, Issue 2, 2004, Pages 445-457

  Ndlebe, V J ^a   Brown, M E ^a   Glass, B D ^b  

^a RHODES UNIVERSITY   (South Africa)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

cyclodextrin; Cyclodextrins; Excipients; Glucose; Thermal stability; Triprolidine; Triprolidine hydrochloride

Indexed keywords

Β-CYCLODEXTRIN; CYCLODEXTRINS; EXCIPIENTS; TRIPROLIDINE; TRIPROLIDINE HYDROCHLORIDE;

CRYSTALLINE MATERIALS; DEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GLUCOSE; INCLUSIONS; ISOMERS; THERMOANALYSIS; THERMODYNAMIC STABILITY; X RAY POWDER DIFFRACTION;

CHLORINE COMPOUNDS;

EID: 4344676991     PISSN: 13886150     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JTAN.0000038985.43887.48     Document Type: Conference Paper

References (24)

1. British Pharmacopoeia, 1 (1998) 1334.
2. United States Pharmacopoeia, 23 (1994) 1605.
3. British Pharmaceutical Codex, (1963) 867.
4. A. F. Casy, C. R. Ganellin, A. D. Mercer and C. Upton, J. Pharm. Pharmacol., 44 (1992) 791.
5. C. O. Wilson, O. G. Gisvaldo and R. F. Doerge, Textbook of Organic Medicinal and Pharmaceutical Chemistry, Raven-Lippincott, Philadelphia, 7th Edn, 1977, Chapter 18.
6. F. H. Metwally, J. Pharm. Biomed. Anal., 26 (2001) 265.
7. J. N. Delgado and W. A. Remers, Textbook of Organic Medicinal and Pharmaceutical Chemistry, J. B. Lippincott Co., Philadelphia, 9th Edn, 1991, pp. 603-626.
8. H. van der Goot and H. Timmerman, Eur. J. Med. Chem., 35 (2000) 5.
9. R. R. Ison, F. M. Franks and K. S. Soh, J. Pharm. Pharmacol., 25 (1973) 887.
10. A. S. Benezra and C.-H. Yang, Analytical Profiles of Drug Substances, 8 (1979) 509.
11. http://www.environment.google/triprolidine-stability.htm, Stability of triprolidine hydrochloride in liquid dosage form, 1997.
12. The Cambridge Structural Database, the Cambridge Crystallographic Data Centre, Cambridge, UK, Structural reference code (TPROLC).
13. M. E. Brown, B. D. Glass and M. S. Worthington, J. Therm. Anal. Cal., 68 (2002) 631.
14. G. Bettinetti, A. Gazzaniga, P. Mura, F. Giordano and M. Setti, Drug Dev. Ind. Pharm., 18 (1992) 39.
15. Y. Nakai, K. Yamamoto, T. Oguchi, E. Yonemochi and T. Hanawa, Chem. Pharm. Bull., 38 (1990) 1345.
16. A. Abdel Rahman, S. I. Saleh, Y. Nakai, A. E. Aboutaleb and M. O. Ahmed, Eur. J. Pharm. Biopharm., 39 (1993) 82.
17. O. Bekers, E. V. Uijtendaal, J. H. Beijnen, A. Bult and W. J. M. Underberg, Drug Dev. Ind. Pharm., 17 (1991) 1503.
18. B. W. Muller and E. Albers, Int. J. Pharm., 79 (1992) 273.
19. S.-Y. Lin and Y.-H. Kao, Int. J. Pharm., 56 (1989) 249.
20. G. A. El-Gendy and M. El-Gendy, Eur. J. Pharm. Biopharm., 39 (1993) 249.
21. I.-K. Chun and D.-S. Yun, Int. J. Pharm., 96 (1993) 91.
22. K. Uekama, S. Narisawa, F. Hirayama and M. Otagiri, Int. J. Pharm., 16 (1983) 327.
23. J.-J. Chen, MSc.Thesis, Rhodes University, 2000, pp. 179-180.
24. B. Pose-Vilarnavo, I. Perdamo-López, M. Echezarreta- López, P. Schroth-Pardo, E. Estrada and J. J. Torres-Labandeira, Eur. J. Pharm. Sci., 13 (2001) 328.